Qualigen Therapeutics Inc. (AIXC)
Market Open
15 Jun, 14:39
NASDAQ (CM) NASDAQ (CM) Primary $
1. 40
+0.01
+0.7194%
$
5.99M Market Cap
- P/E Ratio
- Div Yield
8,459 Volume
-2.7 Eps
$ 1.39
Previous Close Investors:
Want to track AIXC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Qualigen Therapeutics Inc. (AIXC) Statistics
Valuation metrics
Market Cap 5.99M
Enterprise value 971.81K
Trailing P/E (ttm) -0.53
Forward P/E -
PEG ratio -0.04
Price/Sales (ttm) -
Price/Book (mrq) 0.49
Enterprise Value/Revenue -
Enterprise Value/EBITDA -0.05
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 46.81K
Average volume (90 days) 53.98K
Price summary
52-Week low 0.92
52-Week high 8.81
Beta -
50-Day moving average 1.34
200-Day moving average 1.68
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:50
Last split Date 5 Nov 2024
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.85%
Return on equity -0.94%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.65
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.8
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 11.57%
Book value per share (mrq) 2.84
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
